27th Apr 2015 07:17
LONDON (Alliance News) - Sinclair IS Pharma PLC saw its shares rise early Monday after it said that its Silhouette Instalift product has been approved by the US Food and Drug Administration.
The product is used to counter skin-sagging, using a suture-based technique to lift the skin of the face without incisions.
The company is currently evaluating a distribution model for the product in the US.
"I am delighted with today's announcement which represents the biggest growth opportunity in the company's history. Sinclair's strategy is to build a world leading aesthetic portfolio based on innovative and minimally invasive treatments, supported by extensive physician training," said Chief Executive Officer Chris Spooner in a statement.
Shares in Sinclair IS Pharma are trading up 6.9% at 44.89 pence early Monday.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
Sinclair Pharma